Literature DB >> 32818816

Molecular origins of APOBEC-associated mutations in cancer.

Mia Petljak1, John Maciejowski2.   

Abstract

The APOBEC family of cytidine deaminases has been proposed to represent a major enzymatic source of mutations in cancer. Here, we summarize available evidence that links APOBEC deaminases to cancer mutagenesis. We also highlight newly identified human cell models of APOBEC mutagenesis, including cancer cell lines with suspected endogenous APOBEC activity and a cell system of telomere crisis-associated mutations. Finally, we draw on recent data to propose potential causes of APOBEC misregulation in cancer, including the instigating factors, the relevant mutator(s), and the mechanisms underlying generation of the genome-dispersed and clustered APOBEC-induced mutations.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  APOBEC mutations; Cancer cell lines; Cancer mutagenesis; Chromothripsis; Kataegis; Mutational signature

Mesh:

Substances:

Year:  2020        PMID: 32818816      PMCID: PMC7494591          DOI: 10.1016/j.dnarep.2020.102905

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  116 in total

1.  APOBEC-mediated editing of viral RNA.

Authors:  Kate N Bishop; Rebecca K Holmes; Ann M Sheehy; Michael H Malim
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

2.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

3.  Nuclear envelope rupture and repair during cancer cell migration.

Authors:  Celine M Denais; Rachel M Gilbert; Philipp Isermann; Alexandra L McGregor; Mariska te Lindert; Bettina Weigelin; Patricia M Davidson; Peter Friedl; Katarina Wolf; Jan Lammerding
Journal:  Science       Date:  2016-03-24       Impact factor: 47.728

4.  Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.

Authors:  Candace D Middlebrooks; A Rouf Banday; Konichi Matsuda; Krizia-Ivana Udquim; Olusegun O Onabajo; Ashley Paquin; Jonine D Figueroa; Bin Zhu; Stella Koutros; Michiaki Kubo; Taro Shuin; Neal D Freedman; Manolis Kogevinas; Nuria Malats; Stephen J Chanock; Montserrat Garcia-Closas; Debra T Silverman; Nathaniel Rothman; Ludmila Prokunina-Olsson
Journal:  Nat Genet       Date:  2016-09-19       Impact factor: 38.330

5.  Chromothripsis and Kataegis Induced by Telomere Crisis.

Authors:  John Maciejowski; Yilong Li; Nazario Bosco; Peter J Campbell; Titia de Lange
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

6.  APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.

Authors:  James I Hoopes; Luis M Cortez; Tony M Mertz; Ewa P Malc; Piotr A Mieczkowski; Steven A Roberts
Journal:  Cell Rep       Date:  2016-01-28       Impact factor: 9.423

7.  Molecular cloning of an apolipoprotein B messenger RNA editing protein.

Authors:  B Teng; C F Burant; N O Davidson
Journal:  Science       Date:  1993-06-18       Impact factor: 47.728

8.  An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals.

Authors:  Carsten Münk; Anouk Willemsen; Ignacio G Bravo
Journal:  BMC Evol Biol       Date:  2012-05-28       Impact factor: 3.260

9.  Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.

Authors:  Tadahiko Matsumoto; Kotaro Shirakawa; Masaru Yokoyama; Hirofumi Fukuda; Anamaria Daniela Sarca; Sukenao Koyabu; Hiroyuki Yamazaki; Yasuhiro Kazuma; Hiroyuki Matsui; Wataru Maruyama; Kayoko Nagata; Fumiko Tanabe; Masayuki Kobayashi; Keisuke Shindo; Ryo Morishita; Hironori Sato; Akifumi Takaori-Kondo
Journal:  Sci Rep       Date:  2019-06-05       Impact factor: 4.379

10.  Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots.

Authors:  Pégah Jalili; Danae Bowen; Adam Langenbucher; Shinho Park; Kevin Aguirre; Ryan B Corcoran; Angela G Fleischman; Michael S Lawrence; Lee Zou; Rémi Buisson
Journal:  Nat Commun       Date:  2020-06-12       Impact factor: 14.919

View more
  9 in total

1.  APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival.

Authors:  Rongrong Wu; Masanori Oshi; Mariko Asaoka; Michelle R Huyser; Yoshihisa Tokumaru; Akimitsu Yamada; Li Yan; Itaru Endo; Takashi Ishikawa; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

2.  Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B.

Authors:  Justin J King; Faezeh Borzooee; Junbum Im; Mahdi Asgharpour; Atefeh Ghorbani; Cody P Diamond; Heather Fifield; Lesley Berghuis; Mani Larijani
Journal:  ACS Pharmacol Transl Sci       Date:  2021-07-19

3.  Comparative Genomic Analysis Reveals Genetic Variations in Multiple Primary Esophageal Squamous Cell Carcinoma of Chinese Population.

Authors:  Jinxiao Liang; Yinjie Wang; Lei Cai; Jinshi Liu; Junrong Yan; Xin Chen; Xiaoying Wu; Qixun Chen
Journal:  Front Oncol       Date:  2022-04-20       Impact factor: 5.738

4.  The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.

Authors:  Milaid Granadillo Rodríguez; Ben Flath; Linda Chelico
Journal:  Open Biol       Date:  2020-12-09       Impact factor: 6.411

Review 5.  The Safe Path at the Fork: Ensuring Replication-Associated DNA Double-Strand Breaks are Repaired by Homologous Recombination.

Authors:  Jac A Nickoloff; Neelam Sharma; Lynn Taylor; Sage J Allen; Robert Hromas
Journal:  Front Genet       Date:  2021-09-27       Impact factor: 4.772

Review 6.  Metnase and EEPD1: DNA Repair Functions and Potential Targets in Cancer Therapy.

Authors:  Jac A Nickoloff; Neelam Sharma; Lynn Taylor; Sage J Allen; Suk-Hee Lee; Robert Hromas
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

7.  Integrated cohort of esophageal squamous cell cancer reveals genomic features underlying clinical characteristics.

Authors:  Minghao Li; Zicheng Zhang; Qianrong Wang; Yan Yi; Baosheng Li
Journal:  Nat Commun       Date:  2022-09-07       Impact factor: 17.694

8.  The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside.

Authors:  Chenchen Ma; Peng Liu; Siyuan Cui; Chang Gao; Xing Tan; Zhaopeng Liu; Ruirong Xu
Journal:  Molecules       Date:  2022-09-07       Impact factor: 4.927

Review 9.  Global mapping of cancers: The Cancer Genome Atlas and beyond.

Authors:  Carlo Ganini; Ivano Amelio; Riccardo Bertolo; Pierluigi Bove; Oreste Claudio Buonomo; Eleonora Candi; Chiara Cipriani; Nicola Di Daniele; Hartmut Juhl; Alessandro Mauriello; Carla Marani; John Marshall; Sonia Melino; Paolo Marchetti; Manuela Montanaro; Maria Emanuela Natale; Flavia Novelli; Giampiero Palmieri; Mauro Piacentini; Erino Angelo Rendina; Mario Roselli; Giuseppe Sica; Manfredi Tesauro; Valentina Rovella; Giuseppe Tisone; Yufang Shi; Ying Wang; Gerry Melino
Journal:  Mol Oncol       Date:  2021-07-20       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.